Related Experiment Videos
[Electrovaporization of the prostate]
M Cecchi1, C A Sepich, G Pagni
1Clinica Urological I, Dipartimento di Chirurgia, Università di Pisa.
Chirurgia Italiana
|January 1, 1996
Summary
Transurethral electrovaporization of the prostate offers a safe and effective treatment for benign prostatic hyperplasia. This minimally invasive procedure shows significant symptom improvement and low complication rates.
Area of Science:
- Urology
- Minimally Invasive Surgery
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Transurethral resection of the prostate (TURP) is a standard treatment, but newer techniques are emerging.
- Electrovaporization presents a potentially advantageous modification of TURP.
Purpose of the Study:
- To evaluate the efficacy and safety of transurethral electrovaporization for symptomatic benign prostatic hyperplasia.
- To assess patient outcomes and complication rates following the procedure.
Main Methods:
- A cohort of 22 patients with symptomatic BPH underwent electrovaporization using the Circon Acmi Grooved Vaportrode.
- Procedures were performed under general or regional anesthesia.
- Standard electrovaporization techniques were employed.
Main Results:
- Mean operative time was 40 minutes.
- Patients were discharged catheter-free within 1-2 days.
- Statistically significant improvements in symptom scores, peak uroflow, and postvoid residual urine were observed at 3 months (p < 0.01).
- No significant complications were reported.
Conclusions:
- Transurethral electrovaporization of the prostate is a safe, easy, and cost-effective procedure for BPH.
- The technique demonstrates excellent short-term results.
- Long-term efficacy and complication data require further investigation through multicenter clinical trials.